Fig. 1 · Structure
Documents & Downloads
Abiraterone decanoate
Abiraterone Prodrug
Abiraterone decanoate is a prodrug of Abiraterone, designed for controlled release and long-acting inhibition of CYP17. This compound facilitates sustained therapeutic effects through intramuscular delivery, making it suitable for the treatment of metastatic castration-resistant prostate cancer. Its key biological activity enhances the effectiveness of androgen deprivation therapy, contributing valuable insights for oncology research.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2486052-18-8 |
| Applications | Abiraterone Prodrug |
| Formula | C34H49NO2 |
| Molecular Weight | 503.76 |
| SMILES | C[C@@]12[C@](CC=C2C3=CN=CC=C3)([H])[C@@]4([H])[C@@](CC1)([H])[C@@]5(C(C[C@H](CC5)OC(CCCCCCCCC)=O)=CC4)C |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.